People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Biotechnology, Other Health Care, Pharmaceuticals, Other Technology, Business Services, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ocugen, Inc. | — | Biotechnology | Series B | $145.6M | $566.9M | 2012 |
| Active Implants Corp | — | Other Health Care | Series A | $35.8M | $167.9M | 2009 |
| Aeolus Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $18.5M | $209.0M | 2009 |
| Daily Inches, Inc. | — | Other Technology | Series A | $18.4M | $284.3M | 2010 |
| Bye UAS, Inc. | — | Business Services | Seed | $7.5M | $13.6M | 2022 |
| Insight Global, Llc | — | Other | Series A | $5.5M | $83.3M | 2017 |
| Mycroft AI Inc. | — | AI / ML | Seed | $3.6M | $3.3M | 2021 |
| Onward Care, Inc. | — | Healthtech | Seed | $1.8M | $9.0M | 2019 |
| Jabez Biosciences, Inc. | — | Biotechnology | Seed | $1.6M | $991K | 2024 |
| eJOOV, Inc. | — | Other Technology | Pre-Seed | $936K | $18.2M | 2021 |
| Nok Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $817K | $976K | 2024 |
| Posy, Llc | — | Other | Pre-Seed | $310K | $7.2M | 2018 |
Michael Lewis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Lewis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Lewis | 2 | 6 |
| David Mehalick | 2 | 5 |
| Bruce Cassidy | 2 | 5 |
| Michael E Lewis | 2 | 4 |
| Brian Cogley | 2 | 3 |
| Martin Lewis | 2 | 2 |
| Nader Akhnoukh | 2 | 2 |
| John Johnson | 1 | 25 |
| Garheng Kong | 1 | 16 |
| Mark Solon | 1 | 12 |
| Chris Marks | 1 | 8 |
| Amit Kumar | 1 | 8 |
| Brian Wallace | 1 | 8 |
| Kevin Rakin | 1 | 7 |
| Timothy Brown | 1 | 7 |
| Patrick O'Donnell | 1 | 6 |
| Chase Fraser | 1 | 6 |
| Jeffrey Stowell | 1 | 6 |
| Paul Bell | 1 | 6 |
| Eric Williams | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.